Home » Analyst Articles – US

Buffalo Wild Wings (BWLD) Receives Hold Rating from Credit Suisse Group

Buffalo Wild Wings (NASDAQ:BWLD)‘s stock had its “hold” rating reissued by equities research analysts at Credit Suisse Group in a report issued on Wednesday. A number of other equities research analysts also recently weighed in on BWLD. BidaskClub downgraded Buffalo Wild Wings from a “sell” rating to a “strong sell” rating in a research report on Tuesday, January 16th. Barclays dropped their target price on Buffalo Wild Wings from $144.00 to $128.00 and set an “overweight” rating for the company... 
 

Trueblue (TBI) Receives “Hold” Rating from BMO Capital Markets

Trueblue (NYSE:TBI)‘s stock had its “hold” rating restated by investment analysts at BMO Capital Markets in a report released on Wednesday. They presently have a $30.00 price objective on the business services provider’s stock. BMO Capital Markets’ price target indicates a potential upside of 8.11% from the stock’s current price. A number of other research analysts also recently weighed in on the company. Robert W. Baird reissued a “hold” rating and issued a $25.00 price objective on shares of Trueblue... 
 

Cedar Realty Trust (CDR) Raised to “Buy” at Zacks Investment Research

Cedar Realty Trust (NYSE:CDR) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research note issued to investors on Monday. The brokerage presently has a $6.00 price objective on the real estate investment trust’s stock. Zacks Investment Research‘s target price would suggest a potential upside of 8.50% from the stock’s current price. According to Zacks, “Cedar Shopping Centers, Inc. is a fully-integrated real estate investment trust which focuses primarily on ownership,... 
 

Texas Instruments (TXN) Given Outperform Rating at Royal Bank of Canada

Texas Instruments (NASDAQ:TXN)‘s stock had its “outperform” rating reiterated by research analysts at Royal Bank of Canada in a research note issued on Monday, Marketbeat Ratings reports. They currently have a $127.00 target price on the semiconductor company’s stock, up from their prior target price of $112.00. Royal Bank of Canada’s price objective would indicate a potential upside of 5.93% from the company’s previous close. TXN has been the topic of several other reports. Bank of America lifted their target... 
 

ArcBest (ARCB) Upgraded at Zacks Investment Research

ArcBest (NASDAQ:ARCB) was upgraded by Zacks Investment Research from a “hold” rating to a “strong-buy” rating in a note issued to investors on Monday. The firm currently has a $44.00 target price on the transportation company’s stock. Zacks Investment Research‘s target price would suggest a potential upside of 12.97% from the company’s current price. According to Zacks, “ArcBest Corporation provides freight transportation services and solutions. The company’s Freight Transportation segment offers... 
 

Zynga (ZNGA) Downgraded by BidaskClub to Sell

BidaskClub downgraded shares of Zynga (NASDAQ:ZNGA) from a hold rating to a sell rating in a report released on Saturday morning. ZNGA has been the subject of several other reports. Wedbush set a $5.00 target price on shares of Zynga and gave the company a buy rating in a research report on Wednesday, October 18th. Cowen restated a buy rating and issued a $4.50 target price on shares of Zynga in a research report on Thursday, October 12th. Zacks Investment Research upgraded shares of Zynga from a hold rating to a strong-buy rating and set a $4.50... 
 

Prospect Capital (PSEC) Downgraded by Zacks Investment Research

Zacks Investment Research downgraded shares of Prospect Capital (NASDAQ:PSEC) from a buy rating to a hold rating in a research report released on Saturday. According to Zacks, “Prospect Capital Corporation is a closed-end investment company that lends to and invests in private and microcap public businesses. Prospect Capital’s investment objective is to generate both current income and capital appreciation through debt and equity investments. “ PSEC has been the topic of several other reports. National Securities cut their price... 
 

Hydrogenics (HYGS) Downgraded by Zacks Investment Research to “Sell”

Hydrogenics (NASDAQ:HYGS) (TSE:HYG) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a note issued to investors on Wednesday. According to Zacks, “Hydrogenics Corporation develops proton exchange membrane fuel cell systems for commercialization, including related peripheral products and associated diagnostic and control equipment. Hydrogenics is recognized by key customers for its core competency in fuel cell operating systems while establishing a sustainable commercial business... 
 

Tyson Foods (TSN) Upgraded to “Buy” by Zacks Investment Research

Zacks Investment Research upgraded shares of Tyson Foods (NYSE:TSN) from a hold rating to a buy rating in a research note released on Saturday. Zacks Investment Research currently has $89.00 target price on the stock. According to Zacks, “Tyson Foods has surpassed the industry in the past six months owing to strong performance in all business segments, particularly Chicken and Beef. The prepared foods category has also been depicting solid growth, courtesy of rising demand for protein-packed brands and synergies from the AdvancePierre’s... 
 

Visteon (VC) Downgraded to Neutral at JPMorgan Chase & Co.

Visteon (NYSE:VC) was downgraded by stock analysts at JPMorgan Chase & Co. from an “overweight” rating to a “neutral” rating in a research report issued on Monday, Marketbeat Ratings reports. They presently have a $137.00 target price on the auto parts company’s stock, down from their previous target price of $142.00. JPMorgan Chase & Co.’s target price would suggest a potential upside of 7.27% from the company’s previous close. Several other research firms also recently commented on VC. Zacks Investment... 
 

Ventas (VTR) Given a $59.00 Price Target at SunTrust Banks

Ventas (NYSE:VTR) has been given a $59.00 target price by SunTrust Banks in a research note issued to investors on Monday. The firm currently has a “hold” rating on the real estate investment trust’s stock. SunTrust Banks’ target price suggests a potential upside of 5.45% from the stock’s current price. Several other research firms have also issued reports on VTR. Capital One Financial assumed coverage on shares of Ventas in a research report on Monday, September 25th. They set an “equal weight” rating... 
 

Waste Management (WM) Upgraded to Buy by Zacks Investment Research

Zacks Investment Research upgraded shares of Waste Management (NYSE:WM) from a hold rating to a buy rating in a report published on Sunday. They currently have $99.00 price objective on the business services provider’s stock. According to Zacks, “Waste Management is focusing on the core business activities to instill price and cost discipline in order to achieve better margins. The acquisition of Deffenbaugh Disposal will enable Waste Management to extend its geographic footprint and make a foray in the attractive market of Kansas City,... 
 

Zacks Investment Research Lowers Aqua America (WTR) to Hold

Zacks Investment Research cut shares of Aqua America (NYSE:WTR) from a buy rating to a hold rating in a research note released on Sunday. According to Zacks, “Aqua America’s shares have gained higher than the industry in the last 12 months. Aqua America has expanded its customer base through acquisitions during the first nine months of 2017. It aims to increase its customer level by 1.5-2% in 2017 through strategic acquisitions and organic initiatives. Rate hikes are boosting its earnings and the company is continuing with its infrastructural... 
 

Zoetis (ZTS) Given a $78.00 Price Target at BMO Capital Markets

Zoetis (NYSE:ZTS) has been assigned a $78.00 target price by stock analysts at BMO Capital Markets in a research note issued on Monday. The firm presently has a “hold” rating on the stock. BMO Capital Markets’ price objective indicates a potential upside of 0.53% from the stock’s current price. A number of other equities research analysts have also issued reports on ZTS. Cantor Fitzgerald reissued a “buy” rating and set a $75.00 target price on shares of Zoetis in a research note on Tuesday, September 26th.... 
 

Kelly Services (KELYA) Raised to Hold at BidaskClub

BidaskClub upgraded shares of Kelly Services (NASDAQ:KELYA) from a sell rating to a hold rating in a research report released on Saturday morning. Separately, Zacks Investment Research lowered shares of Kelly Services from a strong-buy rating to a hold rating in a research report on Wednesday, January 10th. Kelly Services (KELYA) opened at $28.81 on Friday. Kelly Services has a 12 month low of $20.27 and a 12 month high of $30.93. The firm has a market cap of $1,127.01, a price-to-earnings ratio of 15.08 and a beta of 1.11. Kelly Services (NASDAQ:KELYA)... 
 

Stock Yards Bancorp (SYBT) Stock Rating Lowered by BidaskClub

BidaskClub lowered shares of Stock Yards Bancorp (NASDAQ:SYBT) from a hold rating to a sell rating in a report published on Saturday morning. Separately, Zacks Investment Research lowered Stock Yards Bancorp from a buy rating to a hold rating and set a $42.00 price target on the stock. in a research note on Friday, January 5th. Stock Yards Bancorp (NASDAQ:SYBT) opened at $38.10 on Friday. The company has a market capitalization of $864.88, a price-to-earnings ratio of 20.05 and a beta of 0.69. The company has a debt-to-equity ratio of 0.15, a quick... 
 

BidaskClub Lowers OSI Systems (OSIS) to Strong Sell

BidaskClub cut shares of OSI Systems (NASDAQ:OSIS) from a sell rating to a strong sell rating in a research note published on Saturday morning. A number of other research firms have also issued reports on OSIS. Zacks Investment Research lowered OSI Systems from a buy rating to a hold rating in a report on Wednesday, November 1st. B. Riley restated a buy rating and issued a $108.00 target price on shares of OSI Systems in a report on Tuesday, October 24th. Finally, Jefferies Group restated a buy rating and issued a $79.00 target price on shares... 
 

BidaskClub Lowers Casey's General Stores (CASY) to Buy

Casey's General Stores (NASDAQ:CASY) was downgraded by stock analysts at BidaskClub from a “strong-buy” rating to a “buy” rating in a research note issued on Wednesday. A number of other analysts also recently issued reports on the company. Stephens set a $150.00 target price on Casey's General Stores and gave the stock a “buy” rating in a research report on Friday, January 12th. Zacks Investment Research downgraded Casey's General Stores from a “hold” rating to a “sell”... 
 

FLIR Systems (FLIR) Upgraded by BidaskClub to Buy

BidaskClub upgraded shares of FLIR Systems (NASDAQ:FLIR) from a hold rating to a buy rating in a report released on Saturday. Several other brokerages also recently commented on FLIR. SunTrust Banks increased their price target on FLIR Systems from $37.00 to $43.00 and gave the company a hold rating in a report on Thursday, October 26th. Robert W. Baird reiterated a hold rating and set a $34.00 price target on shares of FLIR Systems in a report on Tuesday, October 24th. Zacks Investment Research upgraded FLIR Systems from a hold rating to a strong-buy... 
 

Patterson-UTI Energy (PTEN) Rating Lowered to Hold at BidaskClub

Patterson-UTI Energy (NASDAQ:PTEN) was downgraded by stock analysts at BidaskClub from a “buy” rating to a “hold” rating in a note issued to investors on Wednesday. Several other equities research analysts have also recently weighed in on the company. Scotiabank upgraded Patterson-UTI Energy from a “sector perform” rating to a “sector outperform” rating in a report on Friday, January 12th. Scotia Howard Weill upgraded Patterson-UTI Energy from a “sector perform” rating to a “sector... 
 

Vertex Pharmaceuticals (VRTX) Rating Increased to Sell at BidaskClub

Vertex Pharmaceuticals (NASDAQ:VRTX) was upgraded by investment analysts at BidaskClub from a “strong sell” rating to a “sell” rating in a report released on Wednesday. VRTX has been the topic of several other research reports. BMO Capital Markets reiterated a “buy” rating on shares of Vertex Pharmaceuticals in a research report on Wednesday, September 27th. Zacks Investment Research lowered Vertex Pharmaceuticals from a “strong-buy” rating to a “hold” rating in a research note on Sunday.... 
 

Kura Oncology (KURA) Lifted to “Buy” at BidaskClub

Kura Oncology (NASDAQ:KURA) was upgraded by investment analysts at BidaskClub from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Wednesday. A number of other equities analysts also recently issued reports on the stock. Cann reaffirmed a “buy” rating on shares of Kura Oncology in a report on Wednesday, November 8th. Citigroup lifted their price objective on shares of Kura Oncology from $15.00 to $19.00 and gave the stock a “buy” rating in a report on Thursday,... 
 

Baldwin & Lyons (BWINB) Rating Increased to Hold at BidaskClub

BidaskClub upgraded shares of Baldwin & Lyons (NASDAQ:BWINB) from a sell rating to a hold rating in a report released on Saturday. Separately, TheStreet upgraded Baldwin & Lyons from a c+ rating to a b- rating in a research report on Wednesday, November 29th. Shares of Baldwin & Lyons (BWINB) opened at $23.80 on Friday. The firm has a market capitalization of $361.62, a price-to-earnings ratio of 54.09 and a beta of 0.89. Baldwin & Lyons has a 52-week low of $21.20 and a 52-week high of $25.40. Baldwin & Lyons (NASDAQ:BWINB)... 
 

Innovative Industrial Properties (IIPR) Stock Rating Upgraded by Zacks Investment Research

Zacks Investment Research upgraded shares of Innovative Industrial Properties (NYSE:IIPR) from a hold rating to a buy rating in a research note published on Saturday. Zacks Investment Research currently has $32.00 price target on the stock. According to Zacks, “Innovative Industrial Properties, Inc. is a real estate investment trust. It focused on the acquisition, ownership and management of specialized industrial properties leased to experienced, state-licensed operators for medical-use cannabis facilities. Innovative Industrial Properties,... 
 

Halozyme Therapeutics (HALO) Lifted to “Buy” at Zacks Investment Research

Halozyme Therapeutics (NASDAQ:HALO) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a report released on Wednesday. The firm presently has a $21.00 price objective on the biopharmaceutical company’s stock. Zacks Investment Research‘s target price points to a potential upside of 6.71% from the company’s previous close. According to Zacks, “Halozyme Therapeutics, Inc. is a therapeutically driven, development stage biopharmaceutical company dedicated to developing... 
 

Zacks Investment Research Downgrades National Australia Bank (NABZY) to Sell

Zacks Investment Research downgraded shares of National Australia Bank (OTCMKTS:NABZY) from a hold rating to a sell rating in a research report released on Saturday morning. According to Zacks, “National Australia Bank is an international financial services group providing a comprehensive and integrated range of financial services. “ National Australia Bank (OTCMKTS NABZY) opened at $11.73 on Friday. The company has a debt-to-equity ratio of 2.55, a quick ratio of 1.18 and a current ratio of 1.18. National Australia Bank has a 1-year... 
 

TUI (TUIFY) Stock Rating Lowered by Zacks Investment Research

Zacks Investment Research lowered shares of TUI (OTCMKTS:TUIFY) from a buy rating to a hold rating in a report issued on Saturday. The firm currently has $12.00 price target on the stock. According to Zacks, “TUI AG provides tourism services. It offers booking of flights, private jet, hotel accommodation and other tourism services; hotel and apartment accommodation to wholesale customers. The company also provides tour operator services for student trips and language courses, travel experiences and adventures, charter yachts, and skiing and... 
 

Bouygues (BOUYF) Upgraded to “Buy” at Zacks Investment Research

Bouygues (OTCMKTS:BOUYF) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a report released on Monday. The firm currently has a $63.00 target price on the stock. Zacks Investment Research‘s price target points to a potential upside of 11.70% from the stock’s previous close. According to Zacks, “Bouygues SA is a diversified industrial group. The company’s business sectors of activity consists of Construction includes building & civil works and energies &... 
 

Barclays Analysts Give Synchrony Financial (SYF) a $53.00 Price Target

Synchrony Financial (NYSE:SYF) has been given a $53.00 price objective by equities research analysts at Barclays in a report released on Monday. The firm presently has a “buy” rating on the financial services provider’s stock. Barclays’ price target suggests a potential upside of 33.23% from the company’s previous close. Other research analysts also recently issued research reports about the company. BTIG Research reissued a “buy” rating and issued a $44.00 target price on shares of Synchrony Financial... 
 

Highwoods Properties (HIW) Given a $51.00 Price Target by SunTrust Banks Analysts

Highwoods Properties (NYSE:HIW) has been assigned a $51.00 price target by research analysts at SunTrust Banks in a note issued to investors on Monday. The firm currently has a “hold” rating on the real estate investment trust’s stock. SunTrust Banks’ price target indicates a potential upside of 5.07% from the stock’s previous close. A number of other brokerages have also recently issued reports on HIW. Bank of America increased their target price on Highwoods Properties from $57.00 to $58.00 and gave the stock a “buy”... 
 

NVIDIA (NVDA) Lowered to Sell at Vetr

NVIDIA (NASDAQ:NVDA) was downgraded by analysts at Vetr from a “hold” rating to a “sell” rating in a research report issued to clients and investors on Monday. They presently have a $224.49 target price on the computer hardware maker’s stock. Vetr‘s target price would indicate a potential downside of 6.04% from the company’s previous close. A number of other equities research analysts have also issued reports on NVDA. Mizuho reissued a “buy” rating on shares of NVIDIA in a research note on Monday,... 
 

Vetr Downgrades Facebook (FB) to Buy

Facebook (NASDAQ:FB) was downgraded by analysts at Vetr from a “strong-buy” rating to a “buy” rating in a research report issued to clients and investors on Tuesday. They currently have a $208.60 price objective on the social networking company’s stock. Vetr‘s price objective would indicate a potential upside of 10.17% from the stock’s current price. Several other equities analysts also recently issued reports on the stock. Morningstar set a $163.00 price objective on shares of Facebook and gave the company... 
 

Mizuho Reaffirms “Hold” Rating for Texas Instruments (TXN)

Texas Instruments (NASDAQ:TXN)‘s stock had its “hold” rating reiterated by stock analysts at Mizuho in a research report issued to clients and investors on Tuesday. They presently have a $107.00 target price on the semiconductor company’s stock. Mizuho’s price target points to a potential downside of 10.75% from the stock’s previous close. A number of other analysts have also issued reports on the company. Drexel Hamilton reissued a “buy” rating and issued a $110.00 target price on shares of Texas... 
 

Sandler O’Neill Reiterates “Hold” Rating for Macerich (MAC)

Macerich (NYSE:MAC)‘s stock had its “hold” rating reissued by investment analysts at Sandler O’Neill in a research report issued to clients and investors on Tuesday. They presently have a $71.00 target price on the real estate investment trust’s stock. Sandler O’Neill’s price target would indicate a potential upside of 3.11% from the company’s previous close. MAC has been the topic of a number of other reports. Boenning Scattergood set a $75.00 price target on shares of Macerich and gave the company... 
 

Edgewell Personal Care (EPC) Downgraded by Zacks Investment Research to Sell

Edgewell Personal Care (NYSE:EPC) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research note issued on Tuesday. According to Zacks, “Edgewell Personal Care Co. manufactures and markets personal care products. The company’s brand consists of Schick(R) and Wilkinson Sword(R) men’s and women’s shaving systems and disposable razors; Edge(R) and Skintimate(R) shave preparations; Playtex(R), Stayfree(R), Carefree(R) and o.b. (R) feminine care products; Banana... 
 

Clearside Biomedical (CLSD) Rating Lowered to Sell at Zacks Investment Research

Clearside Biomedical (NASDAQ:CLSD) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research note issued on Tuesday. According to Zacks, “Clearside Biomedical, Inc. is a biopharmaceutical company is engaged in developing first-in-class drug therapies to treat blinding diseases of the eye using Clearside proprietary suprachoroidal space(TM) microinjector. Its products include CLS-1001 for the treatment of macular edema associated with non-infectious uveitis; CLS-1003 for the treatment... 
 

8X8 (EGHT) Earns “Hold” Rating from William Blair

8X8 (NASDAQ:EGHT)‘s stock had its “hold” rating reiterated by equities researchers at William Blair in a report issued on Tuesday. The analysts wrote, “We remain cautious on 8×8 shares despite investor exuberance related to valuation discrepancy (relative to a public peer) and recently aroused M&A speculation. In our view , the stock appears ahead of itself heading into the print, in light of ongoing sales- and-marketing restructuring, which is likely to take several quarters to execute upon. In the meantime, we... 
 

Cybg (CBBYF) Raised to “Buy” at Zacks Investment Research

Cybg (OTCMKTS:CBBYF) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a report released on Tuesday. The brokerage currently has a $4.00 price objective on the stock. Zacks Investment Research‘s price target would indicate a potential upside of 15.61% from the stock’s current price. According to Zacks, “CYBG PLC provides commercial banking services to retail and institutional customers. It offers savings accounts, telephone banking, insurance, investment management, loans,... 
 

Lumentum (LITE) Given New $62.00 Price Target at MKM Partners

Lumentum (NASDAQ:LITE) had its price target reduced by equities researchers at MKM Partners to $62.00 in a report issued on Tuesday. The brokerage currently has a “buy” rating on the technology company’s stock. MKM Partners’ target price would suggest a potential upside of 40.59% from the stock’s current price. Other equities analysts also recently issued reports about the company. Barclays upgraded Lumentum from an “equal weight” rating to an “overweight” rating and raised their price target... 
 

Bank of America Upgrades Cornerstone OnDemand (CSOD) to “Buy”

Bank of America upgraded shares of Cornerstone OnDemand (NASDAQ:CSOD) from a neutral rating to a buy rating in a report issued on Monday. The brokerage currently has $48.00 price objective on the software maker’s stock, up from their previous price objective of $42.00. Several other research firms have also weighed in on CSOD. Zacks Investment Research lowered Cornerstone OnDemand from a buy rating to a hold rating in a research note on Thursday, January 18th. BidaskClub raised Cornerstone OnDemand from a sell rating to a hold rating in a... 
 

Radius Health’s (RDUS) Hold Rating Reaffirmed at Citigroup

Citigroup reissued their hold rating on shares of Radius Health (NASDAQ:RDUS) in a research report sent to investors on Monday. The brokerage currently has a $43.00 price target on the biopharmaceutical company’s stock. Several other research firms have also issued reports on RDUS. Maxim Group reaffirmed a positive rating on shares of Radius Health in a report on Friday, September 29th. They noted that the move was a valuation call. Zacks Investment Research lowered Radius Health from a hold rating to a sell rating in a report on Wednesday,... 
 

Inter Parfums (IPAR) Downgraded by Citigroup to “Neutral”

Citigroup downgraded shares of Inter Parfums (NASDAQ:IPAR) from a buy rating to a neutral rating in a report released on Monday, MarketBeat.com reports. They currently have $52.00 price target on the stock. IPAR has been the subject of a number of other reports. Zacks Investment Research raised Inter Parfums from a sell rating to a buy rating and set a $53.00 target price for the company in a research report on Tuesday, January 16th. BidaskClub lowered Inter Parfums from a buy rating to a hold rating in a research report on Friday, December 29th.... 
 

Cowen Boosts Royal Dutch Shell (RDS.A) Price Target to $80.00

Royal Dutch Shell (NYSE:RDS.A) had its price target upped by Cowen from $66.00 to $80.00 in a research note issued to investors on Monday. Cowen currently has an outperform rating on the energy company’s stock. Several other brokerages have also recently weighed in on RDS.A. Scotiabank reiterated a hold rating and issued a $67.00 price objective on shares of Royal Dutch Shell in a research note on Friday, December 1st. Piper Jaffray Companies reiterated a buy rating on shares of Royal Dutch Shell in a research note on Thursday, October 19th.... 
 

Mobil'nye Telesistemy PAO (MBT) Lifted to “Overweight” at Morgan Stanley

Morgan Stanley upgraded shares of Mobil'nye Telesistemy PAO (NYSE:MBT) from an equal weight rating to an overweight rating in a research note released on Monday, Marketbeat.com reports. A number of other equities research analysts have also weighed in on the stock. Deutsche Bank lowered shares of Mobil'nye Telesistemy PAO from a buy rating to a hold rating and set a $11.00 target price on the stock. in a report on Wednesday, December 6th. Zacks Investment Research raised shares of Mobil'nye Telesistemy PAO from a strong sell rating to... 
 

Jeld-Wen (JELD) Given Outperform Rating at Credit Suisse Group

Credit Suisse Group reaffirmed their outperform rating on shares of Jeld-Wen (NYSE:JELD) in a report published on Monday morning, The Fly reports. The brokerage currently has a $47.00 target price on the stock, up from their prior target price of $41.00. The analysts noted that the move was a valuation call. A number of other brokerages also recently issued reports on JELD. Robert W. Baird reissued a buy rating and issued a $46.00 price target on shares of Jeld-Wen in a report on Tuesday, January 9th. Barclays set a $44.00 price target on shares... 
 

Credit Suisse Group Reiterates $167.00 Price Target for Intercept Pharmaceuticals (ICPT)

Credit Suisse Group set a $167.00 target price on Intercept Pharmaceuticals (NASDAQ:ICPT) in a research report released on Monday. The firm currently has a buy rating on the biopharmaceutical company’s stock. A number of other brokerages also recently commented on ICPT. Goldman Sachs Group reiterated a neutral rating and issued a $79.00 target price on shares of Intercept Pharmaceuticals in a report on Friday, October 6th. Seaport Global Securities reiterated a buy rating and issued a $136.00 target price on shares of Intercept Pharmaceuticals... 
 

Ao World (AOWDF) Upgraded by Zacks Investment Research to “Hold”

Ao World (OTCMKTS:AOWDF) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research note issued on Tuesday. According to Zacks, “AO World Plc operates as an online retailer of domestic appliances primarily in the United Kingdom. The Company sells washing machines, washer dryers, tumble dryers, dishwashers, fridges and freezers, ovens, cookers, range cookers, cooker hoods, extractor fans, hobs, and microwaves, as well as coffee machines, kettles and toasters, food preparation products,... 
 

Nuance Communications (NUAN) Given “Buy” Rating at Canaccord Genuity

Canaccord Genuity reaffirmed their buy rating on shares of Nuance Communications (NASDAQ:NUAN) in a research report report published on Monday morning. The brokerage currently has a $21.00 price objective on the software maker’s stock. “We take three constructive takeaways from this morning’s announcement: (1) fundamentals are healthy, perhaps marginally improving in certain segments, and growth should continue to inflect as the model transition matures, (2) the firm is being aggressive in its efforts to realign around growth markets,... 
 

Myriad Genetics’ (MYGN) Equal Weight Rating Reiterated at Barclays

Barclays reissued their equal weight rating on shares of Myriad Genetics (NASDAQ:MYGN) in a report issued on Monday, Marketbeat.com reports. They currently have a $35.00 price objective on the stock, up from their previous price objective of $30.00. Several other equities research analysts have also recently commented on the company. Zacks Investment Research cut Myriad Genetics from a strong-buy rating to a hold rating in a research note on Friday, December 15th. ValuEngine cut Myriad Genetics from a buy rating to a hold rating in a research note... 
 

Sandler O’Neill Analysts Give Fidelity Southern (LION) a $25.00 Price Target

Sandler O’Neill set a $25.00 price target on Fidelity Southern (NASDAQ:LION) in a research note released on Monday morning. The brokerage currently has a hold rating on the financial services provider’s stock. Separately, Zacks Investment Research raised shares of Fidelity Southern from a sell rating to a hold rating in a report on Tuesday, January 2nd. Four research analysts have rated the stock with a hold rating, two have given a buy rating and one has given a strong buy rating to the stock. Fidelity Southern has a consensus rating... 
 
© 2006-2018 Ticker Report. Google+.